BMY

59.60

3.45% -2.13

Dopo l'orario di chiusura: 59.56 -0.04 -0.07%

Bristol Myers Squibb Co (BMY)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché BMY Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$61.73

Aprire:

$60.23

Volume 24 ore:

13.60M

Relative Volume:

1.03

Capitalizzazione di mercato:

$121.69B

Reddito:

$48.19B

Utile/perdita netta:

$7.06B

Rapporto P/E:

17.23

EPS:

3.4587

Flusso di cassa netto:

$12.85B

1 W Prestazione:

+0.29%

1M Prestazione:

-4.40%

6M Prestazione:

+30.33%

1 anno Prestazione:

+0.00%

Intervallo 1D:

$59.10

$60.58

Intervallo di 1 settimana:

$58.37

$62.23

Portata 52W:

$42.52

$62.89

Bristol Myers Squibb Co Stock (BMY) Company Profile

Nome

Bristol Myers Squibb Co

Settore

Healthcare (1118)

Industria

Drug Manufacturers - General (20)

Telefono

(609) 252-4621

Indirizzo

ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NY

Dipendente

32,500

Cinguettio

@BMSNEWS

Prossima data di guadagno

2026-04-23

Ultimi documenti SEC

BMY's Discussions on Twitter

Compare BMY vs LLY, JNJ, ABBV, AZN, MRK

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BMY Bristol Myers Squibb Co	59.60	121.69B	48.19B	7.06B	12.85B	3.4587
LLY Lilly Eli Co	935.58	835.81B	65.18B	20.64B	5.96B	22.59
JNJ Johnson Johnson	243.04	585.39B	94.19B	26.80B	19.70B	11.05
ABBV Abbvie Inc	208.84	369.39B	61.16B	4.19B	17.82B	2.3614
AZN Astrazeneca Plc	203.49	315.58B	58.80B	10.24B	8.98B	3.2788
MRK Merck Co Inc	120.87	298.84B	64.93B	18.26B	12.36B	7.2751

Bristol Myers Squibb Co Stock (BMY) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-25	Iniziato	RBC Capital Mkts	Sector Perform
2026-02-20	Iniziato	Barclays	Overweight
2026-01-07	Aggiornamento	UBS	Neutral → Buy
2025-12-15	Aggiornamento	BofA Securities	Neutral → Buy
2025-12-12	Aggiornamento	Guggenheim	Neutral → Buy
2025-11-13	Iniziato	Scotiabank	Sector Perform
2025-08-05	Downgrade	Daiwa Securities	Outperform → Neutral
2025-04-22	Iniziato	Cantor Fitzgerald	Neutral
2025-04-22	Iniziato	Piper Sandler	Overweight
2024-12-16	Aggiornamento	Jefferies	Hold → Buy
2024-12-10	Ripresa	BofA Securities	Neutral
2024-11-15	Iniziato	Wolfe Research	Peer Perform
2024-11-13	Aggiornamento	Daiwa Securities	Neutral → Outperform
2024-11-12	Aggiornamento	Leerink Partners	Market Perform → Outperform
2024-10-25	Downgrade	Citigroup	Buy → Neutral
2024-10-17	Iniziato	Bernstein	Mkt Perform
2024-07-29	Downgrade	Barclays	Overweight → Equal Weight
2024-03-11	Downgrade	Societe Generale	Buy → Hold
2024-02-06	Downgrade	Redburn Atlantic	Buy → Neutral
2024-01-03	Downgrade	BofA Securities	Buy → Neutral
2023-11-15	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2023-11-09	Iniziato	Deutsche Bank	Hold
2023-11-02	Downgrade	Daiwa Securities	Outperform → Neutral
2023-10-27	Downgrade	BMO Capital Markets	Outperform → Market Perform
2023-10-27	Aggiornamento	HSBC Securities	Reduce → Hold
2023-10-27	Downgrade	William Blair	Outperform → Mkt Perform
2023-10-20	Ripresa	UBS	Neutral
2023-07-14	Iniziato	HSBC Securities	Reduce
2023-07-10	Iniziato	SVB Securities	Market Perform
2023-06-28	Iniziato	Daiwa Securities	Outperform
2023-03-06	Iniziato	Jefferies	Hold
2023-01-17	Iniziato	Cantor Fitzgerald	Overweight
2022-11-18	Iniziato	Credit Suisse	Neutral
2022-10-10	Downgrade	Guggenheim	Buy → Neutral
2022-09-14	Downgrade	Berenberg	Buy → Hold
2022-06-03	Downgrade	Raymond James	Outperform → Mkt Perform
2022-04-06	Ripresa	Morgan Stanley	Underweight
2021-12-17	Iniziato	Goldman	Buy
2021-12-09	Ripresa	Wells Fargo	Equal Weight
2021-11-19	Iniziato	BMO Capital Markets	Outperform
2021-11-01	Downgrade	Argus	Buy → Hold
2021-07-27	Ripresa	Truist	Buy
2021-04-30	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-04-13	Aggiornamento	Truist	Hold → Buy
2020-11-16	Aggiornamento	Societe Generale	Hold → Buy
2020-11-10	Ripresa	Bernstein	Mkt Perform
2020-11-06	Downgrade	Gabelli & Co	Buy → Hold
2020-10-19	Aggiornamento	Guggenheim	Neutral → Buy
2020-09-29	Iniziato	Berenberg	Buy
2020-07-28	Iniziato	Raymond James	Outperform
2020-04-02	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-03-23	Downgrade	Societe Generale	Buy → Hold
2020-02-27	Iniziato	Barclays	Equal Weight
2020-01-06	Ripresa	Citigroup	Buy
2019-12-13	Aggiornamento	Argus	Hold → Buy
2019-11-22	Ripresa	Morgan Stanley	Equal-Weight
2019-10-17	Ripresa	BofA/Merrill	Buy
2019-08-14	Aggiornamento	Atlantic Equities	Neutral → Overweight
2019-05-28	Iniziato	Goldman	Buy
2019-05-20	Downgrade	Argus	Buy → Hold
2019-05-03	Aggiornamento	Barclays	Equal Weight → Overweight
2019-05-03	Ripresa	JP Morgan	Overweight
2019-01-15	Aggiornamento	Societe Generale	Sell → Buy
2018-10-22	Downgrade	Citigroup	Buy → Neutral

Mostra tutto

Bristol Myers Squibb Co Borsa (BMY) Ultime notizie

Apr 04, 2026

Case-By-Case Guide As Justices Eye Landmark Pharma Law - Law360

Apr 04, 2026

Trust Co. of Toledo NA OH Sells 55,523 Shares of Bristol Myers Squibb Company $BMY - MarketBeat

Apr 04, 2026

Apr 03, 2026

Elkins, Bristol Myers Squibb CFO, sells $1.85 million in BMY stock - Investing.com Australia

Apr 03, 2026

Bristol-Myers Squibb Cancer Moves And Equity Efforts Underpin Valuation Case - Yahoo Finance UK

Apr 03, 2026

Growth and Income Portfolio's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus

Apr 03, 2026

Bristol-Myers Squibb Company (BMY) Options Chain - Yahoo! Finance Canada

Apr 03, 2026

Apr 02, 2026

Elkins, Bristol Myers Squibb CFO, sells $1.85 million in BMY stock By Investing.com - Investing.com South Africa

Apr 02, 2026

Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors - MarketWatch

Apr 02, 2026